Importantly, miR-34a loss in OSA is associated with enhanced expression of a several targets known to contribute to tumorigenesis including MET, SIRT1, and CDK6 [42, 53, 54] although its contribution to the biology of OSA has not yet been fully elucidated. This evidence concerns the gene MET and obstructive sleep apnea syndrome.